表紙
市場調查報告書

全球女性科技市場 - 分析及預測:2019-2030年

Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030

出版商 BIS Research Inc. 商品編碼 941003
出版日期 內容資訊 英文 203 Pages
商品交期: 最快1-2個工作天內
價格
全球女性科技市場 - 分析及預測:2019-2030年 Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030
出版日期: 2020年06月06日內容資訊: 英文 203 Pages
簡介

全球女性科技市場規模在2019年時推算約有8.206億美元,在預測期間將有12.65%的成長。推動市場的主要因素之一為:女性的感染症狀及慢性病的發病率增加,有效果的個人化治療需求急速增加。此外,近年來,女性的健康意識大幅提升。

此報告研究全球女性科技市場,仔細分析市場驅動力,競爭環境,各領域/各地區的市場,競爭狀況,以及主要企業。

第1章 產品定義

第2章 研究範圍

第3章 研究範圍

  • 1次數據來源
  • 2次數據來源
  • 市場預測模組
  • 研究企業
  • 假設及限制

第4章 產業分析

  • 業界趨勢
    • 過於低估作為決策者的女性
    • 價格及品牌策略
    • 新興國家的女性科技
    • 綜合女性醫療保健的重要性提高
    • 智慧醫療機器及穿戴式設備
    • 無須對月經及更年期感到羞恥
  • 女性科技的創新追蹤器
    • 用於追蹤生育能力的穿戴式設備
    • 監控生育週期的陰道感測器
    • 利用基因學及大數據追蹤生育能力及月經健康
    • 檢查乳癌用的穿戴式設備
  • 法規架構
    • 北美的法規架構
    • 歐洲的法規架構
  • 資金分析
    • 女性科技在過去5年之間獲得10億美金以上的投資
    • 女性科技中值得注目的私人資金

第5章 競爭格局

  • 主要發展及戰略
    • 資金
    • 合作及夥伴
    • 產品的發售及更新
    • 併購
  • 商業模式分析
    • 一對一回饋模式
    • 直接銷售
    • 訂閱制
    • 處方藥遠距醫療模式
  • 產品投射分析

第6章 市場動力

  • 推動市場成長因素
    • 在技術領域中對女性的認知提升
    • 女性健康導致經濟負擔已超過5,000億美元
    • 穿戴式設備成爆發性成長以及女性使用智慧型手機的普及化
  • 阻礙市場成長因素
    • 缺乏女性的決策者
    • 關於女性健康問題的社會禁忌
    • 農村地區中缺乏女性意識
    • 業界主張的背後缺乏科學研究
    • 資本及勞力的調度
    • 女性科技領域中的產品行銷
  • 市場機會
    • 對孕婦,產婦以及出生前及新生兒的護理產品開發之投資
    • 對撒哈拉沙漠以南的非洲進行投資
    • 管理更年期障礙的產品開發

第7章 全球女性科技市場

  • 假設及限制
  • 主要研究結果及機會評估
    • 主要研究結果
    • 市場機會評估

第8章 全球女性科技市場(組件)

  • 概述
  • 行動應用程式
  • 互聯設備
    • 穿戴式互聯設備
    • 非穿戴式互聯設備
  • 服務
  • 其他(有機,智慧女性衛生用品)

第9章 全球女性科技市場(應用)

  • 概述
  • 生育健康
    • 週期追蹤
    • 家庭生育追蹤和監控
  • 一般健康
  • 懷孕及護理
    • 懷孕護理
    • 孕後護理
    • 母乳育兒
    • 其他
  • 骨盆及子宮護理
    • 骨盆護理
    • 月經健康

第10章 全球女性科技市場(末端使用者)

  • 概要
  • 個人
  • 不孕治療診所
  • 醫院/研究機構
  • 診斷中心

第11章 全球女性科技市場(各地區)

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 瑞典
    • 西班牙
    • 法國
    • 荷蘭
    • 其他
  • 亞太
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 印度
    • 其他
  • 中東,南非, 拉丁美洲
    • 中東
    • 南非
    • 拉丁美洲
    • 其他

第12章 企業簡介

  • 概述
  • ALYK,Inc.
  • Aytu BioScience,Inc.
  • Biowink GmbH
  • Bloomlife
  • CORA
  • Flo Health,Inc.
  • Glow, Inc.
  • Inne
  • Kasha
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • Sustain Natural
  • The Flex Company
  • Thinx,Inc.
  • 企業快照
    • Celmatix Inc.
    • Conceivable Inc.
    • Lia Diagnostics Inc.
    • Lucina Health,Inc.( Unified Women's Healthcare, LLC的子公司)
    • Progny, Inc.
    • Univfy Inc.
目錄
Product Code: BH207A

“Global Femtech Market to Reach $3.04 Billion by 2030.”

Market Segmentation

  • Component - Mobile Apps, Connected Devices, Services, Others
  • Application - Reproductive Health, Pregnancy and Nursing Care, Pelvic and Uterine Health, General Health and Wellness
  • End Users- Individuals, Hospitals, Diagnostic Centers, and Fertility Clinics

Regional Segmentation

  • North America - U.S., Canada
  • Europe -Germany, U.K., France, Spain, Netherlands, Sweden, Switzerland, Belgium
  • Asia-Pacific - China, Japan, India, South Korea, and Australia
  • Rest-of-the-World - Saudi Arabia, United Arab Emirates, Israel, South Africa, Brazil and Mexico

Growth Drivers

  • Growing recognition of Women in the Domain of Technology
  • Economic Burden of Women's health is more than $500 Billion
  • Explosion of wearable devices and increasing smartphone penetration among women

Market Challenges

  • Lack of women decision makers
  • Societal taboos surrounding women's health issues
  • Absence of awareness among women in rural areas
  • Lack of scientific studies to back industrial claims

Market Opportunities

  • Investment in product development for maternal, pre- and neo-natal care
  • Investment in sub-Saharan Africa
  • Product development for menopause management

Key Companies Profiled

ALYK, Inc., Aytu BioScience, Inc., Biowink GmbH, CORA, Flo Health, Inc., Bloomlife, Glow, Inc., Inne, Kasha, NaturalCycles Nordic AB, Plackal Tech, Ovia Health, Sustain Natural, The Flex Company, Thinx, Inc., Celmatix Inc., Conceivable Inc., Lia Diagnostics Inc., Lucina Health, Inc., Progny, Inc., Univfy Inc., among others

Key Questions Answered:

  • How has the market evolved in the last five years, and what are the awaited technological advancements in the field of Femtech?
  • What are the major market drivers, challenges, and opportunities in the global Femtech market?
  • What are the underlying structures resulting in the emerging trends within the Femtech industry?
  • What was the market value of the leading segments of the global Femtech market in 2019?
  • What are the influencing factors that may affect the market positioning of the key players?
  • How is industry expected to evolve during the forecast period 2019-2030?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • What are the key business models employed by the femtech companies to standout in the evolving market?
  • What is the growth potential of Femtech in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What are the key regulatory implications in developed and developing regions for Femtech?
  • What was the funding trends for the Femtech companies in the last three years and how would the funding scenario change during the forecast period?

Market Overview

Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.

However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million funding (till 2019). The number of women centric start-ups have significantly multiplied in the recent years. This surge is also primarily attributed to the launch of fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.

Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering a financial support of $23 million.

As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period. One of the major driving factor for the market is increasing incidence of infectious and chronic diseases among the female population leading to surge in demand for effective and more personalized treatment. Furthermore, women's health awareness has significantly increased in recent years. For an instance, it was not until 2004, the cardiovascular diseases were considered medically a threat to women's health. However, campaigns such as the American Heart Association's Go Red for Women campaign and the NHLBI's Heart Truth program have significantly boosted the awareness related to life threatening diseases such as CVD.

Another reason driving the growth of the market is growing prevalence of infectious disease among females in low to middle-income countries due to an unhygienic environment. For an instance, in 2013, 60% of new HIV infections in population younger than 25 years occurred in girls and young women. Also, untreated syphilis in low- and middle-income countries still causes over 200 000 deaths every year.

However, some of the major challenges restraining the growth of the market are: creation of awareness among women, particularly in rural areas, unequal distribution of women as compared to men in investment community, and lack of understanding of women health issues by investors, among others.

Competitive Landscape

The Femtech market comprises over 200 start-ups worldwide, 92 percent of which are founded and led by women. Big names in these areas are developing entirely new solutions such as the Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker. While others focus on building tech platforms and subscription services to make existing products such as birth control and period products more easily accessible.

Although majority of Femtech firms are focusing on the millennials, there are also companies working for women at all ages. For example, Genneve, an online clinic aimed at aiding women entering menopause. Also, other companies such as Madorra and MenoGeni are developing devices and pharmaceutical alternatives to aid in the treatment of menopausal symptoms. Companies are extensively entering new women's health spaces to stand out in the competition. Some of the emerging women's heath spaces are osteoporosis, breast cancer, autoimmune conditions, stroke, thyroid issues, chronic fatigue, anxiety, and depression.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Scope of the Study

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Market Estimation Model
  • 3.4 Companies Profiled
  • 3.5 Assumptions and Limitations

4 Industry Analysis

  • 4.1 Industry Trends
    • 4.1.1 Underrepresentation of Women as Decision Makers
    • 4.1.2 Pricing and Branding Strategies
    • 4.1.3 Femtech in Emerging Economies
    • 4.1.4 Growing Emphasis on Holistic Women Healthcare
    • 4.1.5 Smart Medical Devices and Wearables
    • 4.1.6 Destigmatizing Menstrual Health and Menopause
  • 4.2 Femtech Innovation Tracker
    • 4.2.1 Wearable Devices for Fertility Tracking
    • 4.2.2 Vaginal Sensor for Fertility Cycle Monitoring
    • 4.2.3 Leveraging Genomics and Big Data for Fertility Tracking and Menstrual Health
    • 4.2.4 Wearables for Breast Cancer Screening
  • 4.3 Regulatory Framework
    • 4.3.1 Regulatory Framework in North America
    • 4.3.2 Regulatory Framework in Europe
  • 4.4 Funding Analysis
    • 4.4.1 Femtech Received More Than $1 Billion Over the Last 5 Years
    • 4.4.2 Notable Private Funding in Femtech

5 Competitive Landscape

  • 5.1 Key Developments and Strategies
    • 5.1.1 Funding
    • 5.1.2 Collaborations and Partnerships
    • 5.1.3 Product Launch and Upgradation
    • 5.1.4 Mergers and Acquisitions
  • 5.2 Business Model Analysis
    • 5.2.1 One-for-One Give Back Model
    • 5.2.2 Direct-to-Consumer
    • 5.2.3 Subscription
    • 5.2.4 Prescription Telemedicine Model
  • 5.3 Product Mapping Analysis

6 Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Growing Recognition of Women in the Domain of Technology
    • 6.1.2 Economic Burden by Women's Health is More Than $500 Billion
    • 6.1.3 Explosion of Wearable Devices and Increasing Smartphone Penetration Among Women
  • 6.2 Market Restraints
    • 6.2.1 Lack of Women Decision Makers
    • 6.2.2 Societal Taboos Surrounding Women's Health Issues
    • 6.2.3 Absence of Awareness Among Women in Rural Areas
    • 6.2.4 Lack of Scientific Studies to Back Industrial Claims
    • 6.2.5 Raising Capital and Workforce
    • 6.2.6 Product Marketing in Femtech Space
  • 6.3 Market Opportunities
    • 6.3.1 Investment in Product Development for Maternal, Pre- and Neo-Natal Care
    • 6.3.2 Investment in Sub-Saharan Africa
    • 6.3.3 Product Development for Menopause Management

7 Global Femtech Market

  • 7.1 Assumptions and Limitations
  • 7.2 Key Findings and Opportunity Assessment
    • 7.2.1 Key Findings
    • 7.2.2 Opportunity Assessment

8 Global Femtech Market (by Component)

  • 8.1 Overview
  • 8.2 Mobile Apps
  • 8.3 Connected Devices
    • 8.3.1 Wearable Connected Device
    • 8.3.2 Non-Wearable Connected Device
  • 8.4 Services
  • 8.5 Others (Organic, Smart Female Hygiene Products)

9 Global Femtech Market (by Application)

  • 9.1 Overview
  • 9.2 Reproductive Health
    • 9.2.1 Period Tracking
    • 9.2.2 At-Home Fertility Tracking and Monitoring
  • 9.3 General Wellness
      • 9.3.1.1 Menopause
  • 9.4 Pregnancy and Nursing Care
    • 9.4.1 Pregnancy Care
    • 9.4.2 Post Pregnancy Care
      • 9.4.2.1 Post-Partum Depression
    • 9.4.3 Breastfeeding
    • 9.4.4 Others
  • 9.5 Pelvic and Uterine Care
    • 9.5.1 Pelvic Wellness
    • 9.5.2 Menstrual Health

10 Global Femtech Market (by End User)

  • 10.1 Overview
  • 10.2 Individuals
  • 10.3 Fertility Clinics
  • 10.4 Hospitals and Research Institutes
  • 10.5 Diagnostic Centers

11 Global Femtech Market (By Region)

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 U.K.
    • 11.3.3 Sweden
    • 11.3.4 Spain
    • 11.3.5 France
    • 11.3.6 Netherlands
    • 11.3.7 Rest-of-Europe
      • 11.3.7.1 Switzerland
      • 11.3.7.2 Belgium
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 South Korea
    • 11.4.4 Australia
    • 11.4.5 India
    • 11.4.6 Rest-of-Asia-Pacific
      • 11.4.6.1 New Zealand
  • 11.5 Middle East, South Africa, and Latin America
    • 11.5.1 Middle East
      • 11.5.1.1 Israel
      • 11.5.1.2 Saudi Arabia
      • 11.5.1.3 UAE
    • 11.5.2 South Africa
    • 11.5.3 Latin America
      • 11.5.3.1 Brazil
      • 11.5.3.2 Mexico
    • 11.5.4 Rest-of-Rest -of-the-World (Rest-of-RoW)

12 Company Profiles

  • 12.1 Overview
  • 12.2 ALYK, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Role of ALYK, Inc. in the Global Femtech Market
    • 12.2.3 Recent Developments
    • 12.2.4 SWOT Analysis: ALYK, Inc.
  • 12.3 Aytu BioScience, Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Role of Aytu Bioscience, Inc. in the Global Femtech Market
    • 12.3.3 Financials
    • 12.3.4 Key Insights About Financial Health of the Company
    • 12.3.5 Recent Developments
    • 12.3.6 SWOT Analysis
  • 12.4 Biowink GmbH
    • 12.4.1 Company Overview
    • 12.4.2 Role of Biowink GmbH in the Global Femtech Market
    • 12.4.3 Recent Developments
    • 12.4.4 SWOT Analysis: Biowink GmbH
  • 12.5 Bloomlife
    • 12.5.1 Company Overview
    • 12.5.2 Role of Bloomlife GmbH in the Global Femtech Market
    • 12.5.3 Recent Developments
    • 12.5.4 SWOT Analysis: Bloomlife
  • 12.6 CORA
    • 12.6.1 Company Overview
    • 12.6.2 Role of CORA in the Global Femtech Market
    • 12.6.3 Recent Developments
    • 12.6.4 SWOT Analysis: CORA
  • 12.7 Flo Health, Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Role of Flo Health Inc. in the Global Femtech Market
    • 12.7.3 Recent Developments
    • 12.7.4 SWOT Analysis: Flo Health Inc.
  • 12.8 Glow, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Role of Glow, Inc. in the Global Femtech Market
    • 12.8.3 Recent Developments
    • 12.8.4 SWOT Analysis: Glow, Inc.
  • 12.9 Inne
    • 12.9.1 Company Overview
    • 12.9.2 Role of Inne in the Global Femtech Market
    • 12.9.3 Recent Developments
    • 12.9.4 SWOT Analysis: Inne.
  • 12.10 Kasha
    • 12.10.1 Company Overview
    • 12.10.2 Role of Kasha in the Global Femtech Market
    • 12.10.3 Recent Developments
    • 12.10.4 SWOT Analysis: Kasha
  • 12.11 NaturalCycles Nordic AB
    • 12.11.1 Company Overview
    • 12.11.2 Role of NaturalCycles Nordic AB in the Global Femtech Market
    • 12.11.3 Recent Developments
    • 12.11.4 SWOT Analysis: NaturalCycels Nordic AB
  • 12.12 Ovia Health
    • 12.12.1 Company Overview
    • 12.12.2 Role of Ovia Health Inc. in the Global Femtech Market
    • 12.12.3 Recent Developments
    • 12.12.4 SWOT Analysis: Ovia Health
  • 12.13 Plackal Tech
    • 12.13.1 Company Overview
    • 12.13.2 Role of Plackal Tech in the Global Femtech Market
    • 12.13.3 Recent Developments
    • 12.13.4 SWOT Analysis: Plackal Tech.
  • 12.14 Sustain Natural
    • 12.14.1 Company Overview
    • 12.14.2 Role of Sustain Natural in the Global Femtech Market
    • 12.14.3 Recent Developments
    • 12.14.4 SWOT Analysis: Sustain Natural
  • 12.15 The Flex Company
    • 12.15.1 Company Overview
    • 12.15.2 Role of The Flex Company in the Global Femtech Market
    • 12.15.3 Recent Developments
    • 12.15.4 SWOT Analysis: The Flex Company
  • 12.16 Thinx, Inc.
    • 12.16.1 Company Overview
    • 12.16.2 Role of Thinx Inc. in the Global Femtech Market
    • 12.16.3 Recent Developments
    • 12.16.4 SWOT Analysis: Thinx Inc.
  • 12.17 Company Snapshots
    • 12.17.1 Celmatix Inc.
      • 12.17.1.1 Company Overview
      • 12.17.1.2 Role of Celmatix Inc. in the Global Femtech Market
    • 12.17.2 Conceivable Inc.
      • 12.17.2.1 Company Overview
      • 12.17.2.2 Role of Conceivable Inc. in the Global Femtech Market
    • 12.17.3 Lia Diagnostics Inc.
      • 12.17.3.1 Company Overview
      • 12.17.3.2 Role of Lia Diagnostics Inc. in the Global Femtech Market
    • 12.17.4 Lucina Health, Inc. (Subsidiary of Unified Women's Healthcare, LLC)
      • 12.17.4.1 Company Overview
      • 12.17.4.2 Role of Lucina Health, Inc. in the Global Femtech Market
    • 12.17.5 Progny, Inc.
      • 12.17.5.1 Company Overview
      • 12.17.5.2 Role of Progny, Inc. in the Global Femtech Market
    • 12.17.6 Univfy Inc.
      • 12.17.6.1 Company Overview
      • 12.17.6.2 Role of Univfy Inc. in the Global Femtech Market

List of Tables

  • Table 1: Some of the largest rounds of funding received by Femtech companies in 2019 include:
  • Table 2: Global Femtech Market (by End User), $Million, 2019-2030
  • Table 4.1: Pricing and Branding Strategy in the Global Femtech Market
  • Table 4.2: Celmatix, Inc: Product Portfolio
  • Table 4.3: Regulatory Framework for Femtech Market in North America
  • Table 4.4: Regulatory Framework for Femtech Market in Europe
  • Table 4.5: Venture Capital Firms for Women Health
  • Table 4.6: Private Funding in Global Femtech Market, 2019
  • Table 5.1: Global Femtech Market, Products
  • Table 6.1: Prevalence of Diseases in Women, 2017
  • Table 6.2: Global Mobile Phone Adoption by Women
  • Table 8.1: Mobile Applications for Women Reproductive Health
  • Table 8.1: Femtech Integration in Fertility Treatment
  • Table 9.1: Competitive Analysis
  • Table 9.2: Leading Products
  • Table 9.3: The size of healthcare burden of certain conditions that can be attributed to Menopause
  • Table 9.4: Wearables for Pregnancy Care
  • Table 9.5: Leading Solutions Developed by Healthcare Organizations for Gestational Diabetes Mellitus (GDM) Monitoring
  • Table 9.6: Salient Features of Freely Available Mobile Apps That Help Women to Ease into Postpartum
  • Table 10.1: Privacy Policy Analysis
  • Table 11.1: Breakdown of Funding Under National Women's Health Strategy 2020-2030
  • Table 11.2: Other Innovative Femtech Start-Ups in Israel

List of Figures

  • Figure 1: Global Female Income to Reach $26 Trillion by the End of 2020
  • Figure 2: Average Health Spending by Age and Gender, 2016
  • Figure 3: Global Femtech Market, $Million, 2018-2030
  • Figure 4: Global Femtech Market (by Component Type), Percent Share (%), 2019 and 2030
  • Figure 5: Global Femtech Market (by Region), $Million, 2019, 2025 and 2030
  • Figure 2.1: Global Femtech Market Segmentation
  • Figure 3.1: Global Femtech Market Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Venture Capital Firms Deal Count, 2008-2018
  • Figure 5.1: Share of Key Developments and Strategies, January 2016-March 2020
  • Figure 5.2: Funding Activity Share (by Company), January 2016-March 2020
  • Figure 5.3: Collaborations and Partnerships Share (by Company), January 2016-March 2020
  • Figure 5.4: Product Launches (by Company), January 2016-March 2020
  • Figure 5.5: Mergers and Acquisitions (by Company), January 2016- March 2020
  • Figure 5.6: Global Femtech Market, Product Mapping Analysis, 2019
  • Figure 6.1: Women Health Expenditure in the U.S., $Million, 2016-2020
  • Figure 6.2: Global Wearable Device Adoption by Women, 2018
  • Figure 8.1: Global Femtech Market (by Component)
  • Figure 8.2: Global Femtech Market (Apps), 2018-2030
  • Figure 8.3: Workflow in a Period Tracking Application
  • Figure 8.4: Global Femtech Market (Connected Devices), 2018-2030
  • Figure 8.5: Global Femtech Market (Services), 2018-2030
  • Figure 8.6: Global Femtech Market (Others), 2018-2030
  • Figure 9.1: Global Femtech Market (by Application)
  • Figure 9.2: Global Femtech Market (Reproductive Health), 2018-2030
  • Figure 9.3: Global Femtech Market (General Wellness), 2018-2030
  • Figure 9.4: Global Femtech Market (Pregnancy and Nursing Care), 2018-2030
  • Figure 9.5: Global Femtech Market (Pelvic and Uterine Care), 2018-2030
  • Figure 10.1: Global Femtech Market ( Individual Users), 2018-2030
  • Figure 10.2: Global Femtech Market (Fertility Clinics), 2018-2030
  • Figure 10.3: Global Femtech Market (Hospitals and Research Institutes), 2018-2030
  • Figure 10.4: Global Femtech Market (Diagnostic Centers), 2018-2030
  • Figure 11.1: Global Femtech Market (by Region)
  • Figure 11.2: North America Femtech Market, 2018-2030
  • Figure 11.3: North America: Market Dynamics
  • Figure 11.4: U.S. Femtech Market, 2018-2030
  • Figure 11.5: Canada Femtech Market, 2018-2030
  • Figure 11.6: Europe Femtech Market, 2018-2030
  • Figure 11.7: Europe: Market Dynamics
  • Figure 11.8: Germany Femtech Market, 2018-2030
  • Figure 11.9: U.K. Femtech Market, 2018-2030
  • Figure 11.10: Sweden Femtech Market, 2018-2030
  • Figure 11.11: Spain Femtech Market, 2018-2030
  • Figure 11.12: France Femtech Market, 2018-2030
  • Figure 11.13: Netherlands Femtech Market, 2018-2030
  • Figure 11.14: Rest-of-Europe Femtech Market, 2018-2030
  • Figure 11.15: Asia-Pacific Femtech Market, 2018-2030
  • Figure 11.16: Asia-Pacific: Market Dynamics
  • Figure 11.17: China Femtech Market, 2018-2030
  • Figure 11.18: Japan Femtech Market, 2018-2030
  • Figure 11.19: South Korea Femtech Market, 2018-2030
  • Figure 11.20: Australia Femtech Market, 2018-2030
  • Figure 11.21: India Femtech Market, 2018-2030
  • Figure 11.22: Rest-of-Asia-Pacific Femtech Market, 2018-2030
  • Figure 11.23: Rest-of-the-World Femtech Market, 2018-2030
  • Figure 11.24: Middle East, Africa, and Latin America: Market Dynamics
  • Figure 11.25: Israel Femtech Market, 2018-2030
  • Figure 11.26: Saudi Arabia Femtech Market, 2018-2030
  • Figure 11.27: UAE Femtech Market, 2018-2030
  • Figure 11.28: South Africa Femtech Market, 2018-2030
  • Figure 11.29: Brazil Femtech Market, 2018-2030
  • Figure 11.30: Mexico Femtech Market, 2018-2030
  • Figure 11.31: Rest-of-RoW Femtech Market, 2018-2030
  • Figure 12.1: ALYK, Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.2: ALYK,Inc.: SWOT Analysis
  • Figure 12.3: Aytu Bioscience, Inc.: Product Portfolio for Global Femtech Market
  • Figure 12.4: Aytu Bioscience: Overall Financials, 2016-2018
  • Figure 12.5: Aytu Bioscience, Inc. Revenue (by Region), 2017-2018
  • Figure 12.6: Aytu Bioscience, Inc. R&D Expenditure, 2016-2018
  • Figure 12.7: Aytu Bioscience, Inc: SWOT Analysis
  • Figure 12.8: Biowink GmbH: Product Portfolio for the Global Femtech Market
  • Figure 12.9: Biowink GmbH.: SWOT Analysis
  • Figure 12.10: Bloomlife: Product Portfolio for the Global Femtech Market
  • Figure 12.11: Bloomlife.: SWOT Analysis
  • Figure 12.12: CORA.: Product Portfolio for the Global Femtech Market
  • Figure 12.13: CORA SWOT Analysis
  • Figure 12.14: Flo Health Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.15: Flo Health Inc.: SWOT Analysis
  • Figure 12.16: Glow, Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.17: Glow, Inc.: SWOT Analysis
  • Figure 12.18: Inne.: Product Portfolio for the Global Femtech Market
  • Figure 12.19: Inne. SWOT Analysis
  • Figure 12.20: Kasha.: Product Portfolio for the Global Femtech Market
  • Figure 12.21: Kasha SWOT Analysis
  • Figure 12.22: NaturalCycles Nordic AB.: Product Portfolio for the Global Femtech Market
  • Figure 12.23: NaturalCycels Nordic AB: SWOT Analysis
  • Figure 12.24: Ovia Health.: Product Portfolio for the Global Femtech Market
  • Figure 12.25: Ovia Health: SWOT Analysis
  • Figure 12.26: Plackal Tech: Product Portfolio for the Global Femtech Market
  • Figure 12.27: Plackal Tech.: SWOT Analysis
  • Figure 12.28: Sustain Natural.: Product Portfolio for the Global Femtech Market
  • Figure 12.29: Sustain Natural SWOT Analysis
  • Figure 12.30: The Flex Company.: Product Portfolio for the Global Femtech Market
  • Figure 12.31: The Flex Company SWOT Analysis
  • Figure 12.32: Thinx Inc..: Product Portfolio for the Global Femtech Market
  • Figure 12.33: Thinx Inc. SWOT Analysis